Christoph Henkenberens
0000-0002-0721-5683
2 papers found
Refreshing results…
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy
Missing publications? Search for publications with a matching author name.